Author

Nicla Lorito

University of FlorenceORCID 0000-0003-2354-2622Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Andrea MorandiiD· 2 shared Alessia CorradoiD· 1 shared Alexandra AvgustinovaiD· 1 shared Alfredo SmirigliaiD· 1 shared Amalia GastaldelliiD· 1 shared Angela BachiiD· 1 shared Angela SubbianiiD· 1 shared Danilo TatoniiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Andrea MorandiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyHepatology CommunicationsPeer-reviewedJan 29, 2026

MAPK15 Protects Against The Development Of Metabolic Dysfunction-Associated Steatotic Liver Disease

Giovanni Inzalaco, Sara Gargiulo, Denise Bonente…·Mario Chiariello

This study identifies MAPK15 as a protective factor against MASLD by regulating lipid homeostasis and CD36 expression in the liver.

4 citationstop 2%

𝕏 PostBluesky

Cancer BiologyEMBO Molecular MedicinePeer-reviewedJun 26, 2024

FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer

Nicla Lorito, Angela Subbiani, Alfredo Smiriglia…·Andrea Morandi

The paper identifies FADS1/2-mediated lipid metabolic reprogramming as a driver of ferroptosis sensitivity in triple-negative breast cancer, showing that high FADS1/2 expression correlates with poor prognosis and susceptibility to ferroptosis-inducing agents.

118 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky